By Jenny Bryan2000-11-30T00:00:00
The huge rise in the type-2 diabetes population - and the introduction of major new drug treatments - is set to pose some increasingly tough management decisions, writes Jenny Bryan
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud